What is the Acadia Study?
This study is comparing how well budesonide/albuterol or albuterol works as a rescue inhaler in adolescents with asthma. Adding an inhaled corticosteroid (ICS) such as budesonide into rescue inhalers helps to relieve asthma symptoms and prevent flare-ups in adults. To understand whether this also works for adolescents, we will compare: A rescue inhaler without an ICS (albuterol alone) A rescue inhaler with an ICS (budesonide/albuterol combined) Budesonide and albuterol are separately approved in children as young as 1 year old. Budesonide/albuterol is approved in adults.
You may qualify if you are:
- You are 12-17 years old
- Use a daily inhaler
- Have needed to use a rescue inhaler
Those who qualify may receive:
- Reimbursement for travel
- Study-related care from local doctors and specialists
- No-cost study medication
To learn more or see if your child qualifies for our pediatric asthma study, call or contact Danielle Allen, LPN, CCRC today: